Physician Wealth Advisors Inc. Cuts Stock Position in The Procter & Gamble Company (NYSE:PG)

Physician Wealth Advisors Inc. lowered its position in The Procter & Gamble Company (NYSE:PG) by 5.8% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 4,270 shares of the company’s stock after selling 265 shares during the period. Physician Wealth Advisors Inc.’s holdings in Procter & Gamble were worth $666,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Advantage Trust Co acquired a new position in Procter & Gamble during the fourth quarter worth $28,000. Wyrmwood Management LLC purchased a new stake in shares of Procter & Gamble during the fourth quarter worth $29,000. Naples Money Management LLC purchased a new stake in shares of Procter & Gamble during the fourth quarter worth $29,000. Transcendent Capital Group LLC purchased a new stake in shares of Procter & Gamble during the fourth quarter worth $31,000. Finally, Criterion Capital Advisors LLC purchased a new stake in shares of Procter & Gamble during the fourth quarter worth $33,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Insider Transactions at Procter & Gamble

In other news, CEO R. Alexandra Keith sold 855 shares of the firm’s stock in a transaction that occurred on Monday, April 22nd. The shares were sold at an average price of $158.50, for a total transaction of $135,517.50. Following the transaction, the chief executive officer now directly owns 4,004 shares in the company, valued at $634,634. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In related news, CEO Sundar G. Raman sold 31,924 shares of Procter & Gamble stock in a transaction on Monday, May 20th. The shares were sold at an average price of $166.95, for a total value of $5,329,711.80. Following the transaction, the chief executive officer now directly owns 19,042 shares in the company, valued at approximately $3,179,061.90. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO R. Alexandra Keith sold 855 shares of Procter & Gamble stock in a transaction on Monday, April 22nd. The shares were sold at an average price of $158.50, for a total transaction of $135,517.50. Following the completion of the transaction, the chief executive officer now owns 4,004 shares in the company, valued at $634,634. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 154,544 shares of company stock worth $25,413,051. Insiders own 0.17% of the company’s stock.

Procter & Gamble Stock Down 1.0 %

NYSE:PG traded down $1.70 during mid-day trading on Friday, hitting $164.92. The stock had a trading volume of 9,253,317 shares, compared to its average volume of 6,088,934. The stock has a 50-day simple moving average of $165.60 and a two-hundred day simple moving average of $158.81. The company has a market capitalization of $389.23 billion, a PE ratio of 26.95, a PEG ratio of 3.35 and a beta of 0.42. The Procter & Gamble Company has a twelve month low of $141.45 and a twelve month high of $169.41. The company has a current ratio of 0.69, a quick ratio of 0.48 and a debt-to-equity ratio of 0.49.

Procter & Gamble (NYSE:PG) last issued its earnings results on Friday, April 19th. The company reported $1.52 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.10. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. The firm had revenue of $20.20 billion for the quarter, compared to analysts’ expectations of $20.43 billion. During the same quarter last year, the company earned $1.37 earnings per share. The firm’s revenue was up .6% compared to the same quarter last year. On average, equities research analysts anticipate that The Procter & Gamble Company will post 6.55 EPS for the current year.

Procter & Gamble Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th were given a dividend of $1.0065 per share. The ex-dividend date was Thursday, April 18th. This is a positive change from Procter & Gamble’s previous quarterly dividend of $0.94. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.44%. Procter & Gamble’s dividend payout ratio (DPR) is 65.85%.

Wall Street Analysts Forecast Growth

PG has been the subject of a number of analyst reports. Jefferies Financial Group upped their price objective on shares of Procter & Gamble from $175.00 to $182.00 and gave the company a “buy” rating in a report on Monday, April 22nd. Argus upped their price objective on shares of Procter & Gamble from $180.00 to $185.00 and gave the company a “buy” rating in a report on Thursday, April 25th. StockNews.com raised shares of Procter & Gamble from a “hold” rating to a “buy” rating in a research note on Tuesday, June 25th. Barclays increased their target price on shares of Procter & Gamble from $168.00 to $170.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 23rd. Finally, Deutsche Bank Aktiengesellschaft lowered their target price on shares of Procter & Gamble from $172.00 to $171.00 and set a “buy” rating for the company in a research note on Monday, April 22nd. Six research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $170.72.

About Procter & Gamble

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.